# Donor-Alloantigen-Reactive Regulatory T Cell (darTreg) Therapy in Renal Transplantation (The ONE Study )

> **NCT02244801** · PHASE1 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 6 (actual)

## Conditions studied

- Kidney Disease

## Interventions

- **DRUG:** darTreg infusion

## Key facts

- **NCT ID:** NCT02244801
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2017-09
- **Final completion:** 2018-08-28
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2018-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02244801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02244801, "Donor-Alloantigen-Reactive Regulatory T Cell (darTreg) Therapy in Renal Transplantation (The ONE Study )". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02244801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*